Elevance Health (ELV) Change in Cash (2010 - 2026)

Elevance Health (ELV) has reported Change in Cash for 17 consecutive years, with $575.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Cash fell 45.75% year-over-year to $575.0 million; the TTM figure through Jun 2026 stood at $1.7 billion (down 20.68% YoY), while the FY2025 annual figure was $1.2 billion, down 34.19% from the prior year.
• Change in Cash climbed to $575.0 million in Q2 2026 per ELV's latest filing, from $166.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $2.8 billion in Q1 2023 and bottomed at -$4.4 billion in Q4 2023.
• Historically, Change in Cash has averaged $301.0 million across 5 years, with a median of $381.5 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Cash soared 941.38% — and 2023, when it sank 195.82%.
• Elevance Health's Change in Cash stood at -$1.5 billion in 2022, then tumbled by 195.82% to -$4.4 billion in 2023, then surged by 110.65% to $468.0 million in 2024, then soared by 66.24% to $778.0 million in 2025, then slipped by 26.09% to $575.0 million in 2026.
• Business Quant data shows ELV's Change in Cash at $575.0 million in Q2 2026, $166.0 million in Q1 2026, and $778.0 million in Q4 2025.